Latest & greatest articles for corticosteroids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on corticosteroids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on corticosteroids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for corticosteroids

181. Systematic review and meta-analysis: Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma

Systematic review and meta-analysis: Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your (...) in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma Article Text Therapeutics Systematic review and meta-analysis Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma Neil C Thomson Statistics from Altmetric.com Commentary on: Normansell R , Walker S , Milan SJ , et al . Omalizumab for asthma in adults and children . Request Permissions If you wish to reuse any or all

2014 Evidence-Based Medicine

182. Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome. (Abstract)

Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome. Neuro-Behçet Syndrome (NBS) is a severe chronic inflammatory vascular disease involving the Central Nervous System (CNS), and it is an invalidating condition with disability and a huge impact on quality of life. Recommendations on treatments for NBS include the use of disease-modifying therapies in general, although they are not supported by a systematic review of the evidence.To assess (...) the benefit and harms of available treatments for NBS, including biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha.We searched the following databases up to 30 September 2014: Trials Specialised Register of The Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group, CENTRAL, MEDLINE, EMBASE, CINAHL, LILACS, ORPHANET, Clinicaltrials.gov and World Health Organization (WHO) International Clinical Trials Registry Portal.Randomised controlled trials

2014 Cochrane

183. Systematic review and meta-analysis: Inconclusive evidence about the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children

Systematic review and meta-analysis: Inconclusive evidence about the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children Inconclusive evidence about the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children Article Text Therapeutics Systematic review and meta-analysis Inconclusive evidence about the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children Helen K Reddel , Juliet M Foster Statistics from Altmetric.com Commentary on: Chauhan BF , Chartrand C , Ducharme FM . Intermittent versus daily inhaled

2014 Evidence-Based Medicine

184. Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia: The START Randomized Clinical Trial. Full Text available with Trip Pro

Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia: The START Randomized Clinical Trial. Biliary atresia is the most common cause of end-stage liver disease in children. Controversy exists as to whether use of steroids after hepatoportoenterostomy improves clinical outcome.To determine whether the addition of high-dose corticosteroids after hepatoportoenterostomy is superior to surgery alone in improving biliary drainage and survival

2014 JAMA Controlled trial quality: predicted high

185. Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain

Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Sacroiliac joint injections with corticosteroids

2014 Health Technology Assessment (HTA) Database.

186. Randomised controlled trial: A 5-day course of systemic corticosteroids is adequate to treat acute exacerbations of chronic obstructive pulmonary disease

Randomised controlled trial: A 5-day course of systemic corticosteroids is adequate to treat acute exacerbations of chronic obstructive pulmonary disease A 5-day course of systemic corticosteroids is adequate to treat acute exacerbations of chronic obstructive pulmonary disease | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use (...) cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A 5-day course of systemic corticosteroids is adequate to treat acute exacerbations of chronic obstructive

2014 Evidence-Based Medicine

187. Topical corticosteroids effective for nasal polyps

Topical corticosteroids effective for nasal polyps Topical corticosteroids effective for nasal polyps | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Topical corticosteroids effective for nasal polyps Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2013 Cochrane PEARLS

188. Corticosteroids and Prophylaxis. What complications should you try to prevent in patients on chronic corticosteroids?

diagnosed with systemic sarcoidosis. The patient is started on prednisone 40mg with the plan to decrease the dose after remission of symptoms, which may take a number of months. What kind of prophylaxis should the patient receive? Corticosteroids are an effective treatment option for a number of diseases spanning many specialties. However, long-term corticosteroid treatment is marred with a number of side effects including hypertension, hyperglycemia, weight gain, adrenal suppression, osteoporosis, [1,2 (...) . N Engl J Med. 1976;294(9):473-479. 16. Messer J, Reitman D, Sacks HS, Smith H, Jr., Chalmers TC. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med. 1983;309(1):21-24. 17. Conn HO, Poynard T. Adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med. 1984;310(3):201-202. 18. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114(9):735-740. 19

2013 Clinical Correlations

189. Cost-effectiveness of exercise therapy after corticosteroid injection for moderate to severe shoulder pain due to subacromial impingement syndrome: a trial-based analysis Full Text available with Trip Pro

Cost-effectiveness of exercise therapy after corticosteroid injection for moderate to severe shoulder pain due to subacromial impingement syndrome: a trial-based analysis To perform a cost-effectiveness analysis of subacromial corticosteroid injection combined with exercise compared with exercise alone in patients with moderate to severe shoulder pain from subacromial impingement syndrome.A within-trial cost-effectiveness analysis with 232 patients randomized to physiotherapy-led injection

2013 EvidenceUpdates Controlled trial quality: uncertain

190. Cost-effectiveness of exercise therapy after corticosteroid injection for moderate to severe shoulder pain due to subacromial impingement syndrome: a trial-based analysis

Cost-effectiveness of exercise therapy after corticosteroid injection for moderate to severe shoulder pain due to subacromial impingement syndrome: a trial-based analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2013 NHS Economic Evaluation Database.

191. Corticosteroids for a sore throat?

Corticosteroids for a sore throat? Corticosteroids for a sore throat? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Corticosteroids for a sore throat? View/ Open Date 2013-07 Format Metadata Abstract Consider prescribing a single dose of corticosteroids for patients with sore throat, which has been found to bring

2013 PURLS

192. Corticosteroids for presumed pneumocystis pneumonia in patients with HIV infection

Corticosteroids for presumed pneumocystis pneumonia in patients with HIV infection Corticosteroids for presumed pneumocystis pneumonia in patients with HIV infection Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Corticosteroids for presumed pneumocystis pneumonia in patients with HIV infection View/ Open Date 2013-07 (...) Format Metadata Abstract Adjunctive corticosteroids decrease mortality in patients with HIV infection who have moderate to severe hypoxemia and suspected or confirmed pneumocystis pneumonia. Corticosteroids lead to a higher incidence of herpetic lesions, but not other opportunistic conditions. (Strength of recommendation: A, based on a systematic review of randomized controlled trials [RCTs].) URI Citation American Family Physician 88(2) 2013 Collections hosted by hosted by

2013 Clinical Inquiries

193. Use of Corticosteroids before the extraction of Third Molars to reduce post-operative Edema

Use of Corticosteroids before the extraction of Third Molars to reduce post-operative Edema UTCAT2561, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Use of Corticosteroids Before the Extraction of Third Molars to Reduce Post-Operative Edema Clinical Question Can pre-medication with corticosteroids help in reduction of edema, following extraction of third molars? Clinical Bottom Line Pre-medication (...) with corticosteroids when extracting third molars allows mild-moderate reduction in edema after surgery. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Markiewwicz/2008 10 Clinical Trial Total patients 513 Meta-Analysis, Research support (Non-US Gov) Key results In this study two Treatment groups were used, One receiving Corticosteroids (245 patients) before the extraction of Third molars & the second Control group

2013 UTHSCSA Dental School CAT Library

194. Optimal Dose of Intra-articular Corticosteroids for Adhesive Capsulitis: A Randomized, Triple-Blind, Placebo-Controlled Trial. (Abstract)

Optimal Dose of Intra-articular Corticosteroids for Adhesive Capsulitis: A Randomized, Triple-Blind, Placebo-Controlled Trial. Intra-articular corticosteroid injection is a commonly used therapy for adhesive capsulitis, but there are only few studies that compare the efficacy of corticosteroids according to different doses.To determine whether intra-articular injections with a high-dose corticosteroid improves pain and function in patients with adhesive capsulitis better than a low dose (...) , and internal rotation especially for the low- and high-dose groups compared with the placebo. Yet, no significant difference was found between the 2 different corticosteroid dose groups.We assessed the efficacy of corticosteroid injections according to 2 different doses that are most widely used in intra-articular injections for adhesive capsulitis. This study shows that there were no significant differences between the high- and low-dose corticosteroid groups, indicating the preferred use of a low dose

2013 EvidenceUpdates Controlled trial quality: predicted high

195. Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the beta2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial Full Text available with Trip Pro

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the beta2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial The inhaled corticosteroid fluticasone furoate (FF) in combination with the long-acting β2 agonist vilanterol (VI) is in development for asthma and chronic obstructive pulmonary disease.To assess the safety and tolerability of FF/VI over 52 weeks in patients (...) with asthma.Patients (aged ≥12 years; on inhaled corticosteroid) were randomised (2:2:1) to FF/VI 100/25 µg or FF/VI 200/25 µg once daily in the evening, or fluticasone propionate (FP) 500 µg twice daily. Safety evaluations included adverse events (AEs), non-fasting glucose, potassium, 24-h urinary cortisol excretion, ophthalmic assessments, heart rate and pulse rate.On-treatment AEs were similar across groups (FF/VI 66-69%; 73% FP). Oral candidiasis/oropharyngeal candidiasis was more common with FF/VI (6-7%) than

2013 EvidenceUpdates Controlled trial quality: uncertain

196. Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal (Abstract)

Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal This report characterizes acute rejection and rejection outcomes in subjects randomized to continuous corticosteroid therapy (CCS) or early corticosteroid withdrawal (CSWD; 7 days after transplantation) in the Astellas Blinded CSWD Trial.The Astellas Blinded CSWD Trial was a 5-year, prospective, multicenter, randomized, double-blind trial of early

2013 EvidenceUpdates Controlled trial quality: predicted high

197. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Full Text available with Trip Pro

Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Ocular infestation with Toxoplasma gondii, a parasite, may result in inflammation in the retina, choroid, and uvea and consequently lead to complications such as glaucoma, cataract, and posterior synechiae.The objective of this systematic review was to assess the effects of adjunctive use of corticosteroids for ocular toxoplasmosis.We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane (...) . Included trials would have compared anti-parasitic therapy plus corticosteroids versus anti-parasitic therapy alone, or different doses or times of initiation of corticosteroids.Two authors independently screened titles and abstracts retrieved from the electronic searches. We retrieved full-text articles of studies categorized as 'unsure' or 'include' after review of the abstracts. Two authors independently reviewed each full-text article. Discrepancies were resolved through discussion.The electronic

2013 Cochrane

198. Review: Adding corticosteroids to antibiotics improves pain relief in patients with sore throat. (Abstract)

Review: Adding corticosteroids to antibiotics improves pain relief in patients with sore throat. 23552984 2013 05 13 2013 04 04 1539-3704 158 6 2013 Mar 19 Annals of internal medicine Ann. Intern. Med. ACP Journal Club. Review: adding corticosteroids to antibiotics improves pain relief in patients with sore throat. JC11 10.7326/0003-4819-158-6-201303190-02011 Attia Magdy W MW Alfred I. DuPont Hospital for Children Wilmington, Delaware, USA. eng Comment Journal Article United States Ann Intern

2013 Annals of Internal Medicine

199. Review: Corticosteroid plus LABA inhalers, vs LABAs alone, reduce morbidity in COPD. (Abstract)

Review: Corticosteroid plus LABA inhalers, vs LABAs alone, reduce morbidity in COPD. 23420259 2013 04 11 2013 02 19 1539-3704 158 4 2013 Feb 19 Annals of internal medicine Ann. Intern. Med. ACP Journal Club. Review: corticosteroid plus LABA inhalers, vs LABAs alone, reduce morbidity in COPD. JC9 10.7326/0003-4819-158-4-201302190-02009 Aaron Shawn D SD eng Comment Journal Article United States Ann Intern Med 0372351 0003-4819 Cochrane Database Syst Rev. 2012;9:CD006829 22972099 2013 2 20 6 0

2013 Annals of Internal Medicine

200. Physician-, biomarker-, and symptom-based adjustment of inhaled corticosteroids for asthma had similar effects. Full Text available with Trip Pro

Physician-, biomarker-, and symptom-based adjustment of inhaled corticosteroids for asthma had similar effects. 23318340 2013 03 11 2013 01 15 1539-3704 158 2 2013 Jan 15 Annals of internal medicine Ann. Intern. Med. ACP Journal Club. Physician-, biomarker-, and symptom-based adjustment of inhaled corticosteroids for asthma had similar effects. JC6 10.7326/0003-4819-158-2-201301150-02006 Stanbrook Matthew B MB University Health Network, University of Toronto, Ontario, Canada. eng Comment

2013 Annals of Internal Medicine